SFS
CLVS

Sowell Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Sowell Financial Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,520
Closed -$26K – 3046
2021
Q1 		$26K Buy
4,520
+1,635
+57% +$11K ﹤0.01% 1947
2020
Q4 		$14K Sell
2,885
-665
-19% -$3.36K ﹤0.01% 1897
2020
Q3 		$21K Sell
3,550
-360
-9% -$2.15K ﹤0.01% 1552
2020
Q2 		$26K Buy
3,910
+700
+22% +$5.3K ﹤0.01% 1384
2020
Q1 		$20K Hold
3,210
– – ﹤0.01% 1405
2019
Q4 		$33K Buy
3,210
+2,545
+383% +$18.5K ﹤0.01% 1291
2019
Q3 		$3K Buy
+665
New +$5.38K ﹤0.01% 2005

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return